Press and Public Relations

Press and Public Relations

Press Officer and Head of Press and Public Relations (in ch.)

Dr. Sibylle Kohlstädt

Im Neuenheimer Feld 280
69120 Heidelberg

Phone: +49 6221 422854
Fax: +49 6221 422968

E-Mail: s.kohlstaedt@dkfz.de
or presse@dkfz.de

Recent Press Releases

No. 55 | 10. November 2017 | by Koh

A vaccine against cervical cancer for poor countries

Model of a human papillomavirus
© DKFZ

A novel vaccine against cancer-causing human papillomaviruses (HPV) is intended to help raise vaccination rates especially in developing countries. To this end, scientists from the German Cancer Research Center (DKFZ) in Heidelberg are developing a completely new vaccination concept based on a low-cost vaccine that protects from almost all known oncogenic HPV types. The project has now been chosen for funding from the Helmholtz Validation Fund. The Helmholtz Association uses this fund to support promising research projects on their way to marketable applications.

learn more

No. 54 | 08. November 2017 | by Koh

Misregulated protein breakdown promotes leukemias and brain cancer

Blood cancer is initiated by leukemic stem cells characterized by a specifi...
© Simon Raffel, DKFZ

An enzyme that is responsible for the breakdown of specific amino acids in food plays a key role in the development of leukemias and brain cancer, scientists from the German Cancer Research Center (DKFZ) in Heidelberg have now reported in Nature. The researchers have hence discovered a surprising link between energy metabolism and the so-called "epigenetic code". These labels in the DNA of cancer stem cells determine the activity of genes and, thus, many cellular functions. The authors think that blocking this enzyme is a promising possibility to combat cancer.

learn more

No. 53c | 06. November 2017 | by Koh

Rare pancreatic cancer reveals targets for therapy

© Wellcome Library, London

Scientists from the German Cancer Research Center (DKFZ) have conducted comprehensive molecular analyses of a rare type of pancreatic cancer. They have discovered a variety of cellular alterations that can be targeted by drugs that are already available and in part even already approved for therapy.

learn more

Audio (in German only)

more

einblick (in German only)

Publications

Videos (in German only)

RSS-Feed

Subscribe to our RSS-Feed.

to top